PGE 20mcg/ml Injection Recalled Due to Sterility Assurance Concerns
Pacific Healthcare, Inc dba B&B Pharmacy is recalling PGE 20mcg/ml Injection vials due to FDA inspection findings of GMP violations that may impact sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of serious injury or infection.
Plain-English summary
Pacific Healthcare, Inc dba B&B Pharmacy is recalling 3 vials of PGE 20mcg/ml Injection, 10 mL vial, Rx. The product was distributed in California and New Jersey. Specific lot codes and expiration dates are listed in the recall documentation.
The recall was initiated because an FDA inspection identified Good Manufacturing Practice (GMP) violations that potentially impact product quality and sterility. There is a lack of assurance of sterility for the affected units.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling pharmacy for instructions on return or disposal.
The recalled product
- Product
- PGE 20mcg/ml Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA
- Manufacturer
- Pacific Healthcare, Inc dba B&B Pharmacy
- Category
- Drug — Injectable
- Hazard
- Affected units
- 3
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- 05072015@7
- exp 11/3/2015
- 05182015@3
- 11/14/2015
- 07152015@
- 1/11/2016
Distribution
Part of a larger recall action
This product is one of 16 recalled by Pacific Healthcare, Inc dba B&B Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Pacific Healthcare, Inc dba B&B Pharmacy
See all →- SevereNandrolone Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-18
- SevereB&B Pharmacy Recalls PAPA/PHENTO Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-18
- SevereTestosterone Cypionate Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-18
- SevereStanozolol Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-18
- SeverePGE 25mcg/ml Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-18
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereFDA Recalls PGE Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-01-15
- SevereMeditech Formula 0 Injection Recalled for Sterility Assurance Issues
FDA (Drugs) · 2016-04-13
- SevereKey Pharmacy Recalls PGE1 Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereHCG Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereB-Complex Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereFDA Recalls Alprostadil Injection Due to Sterility Concerns
FDA (Drugs) · 2015-09-23